Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Schultze SPAC II in talks to merge with Point Blank Enterprises
Schultze SPAC Is in Talks to Merge With Body Armor Maker Point Blank Enterprises
Blank-check firm Schultze Special Purpose Acquisition Corp. II (NASDAQ:SAMA) is in talks to merge with Point Blank Enterprises Inc., a maker of body armor, holsters, shields and other ballistic protection products, according to people with knowledge of the matter.
Founded in 1973, Pompano Beach, Florida-based Point Blank Enterprises is backed by private equity firm JLL Partners. Led by Chief Executive Officer Daniel Gaston, the company provides products to clients including the US military, federal agencies and domestic and international law-enforcement professionals, according to its website.
READ
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...